Integrated Chemical Profiling, Network Pharmacology, and Zebrafish/Cellular Models Identify Potential Anti-Osteoporotic Constituents of Cynomorium songaricum Rupr.
Current Issues in Molecular Biology · 30.10.2026 · 48 (11) · 1137
DOI: 10.3390/cimb48111137 ↗Kurz gefasst
Fachartikel in der Zeitschrift Current Issues in Molecular Biology, online erschienen am 30.10.2026. Verfasst von Yajing Li und 10 weiteren Autor:innen. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Jilin Provincial Key Research and Development Plan Project, Pilot Selection Projects of Universities and Research Institutes in Changchun.
Abstract (Originalsprache)
Cynomorium songaricum Rupr. (CSR) is extensively utilized in traditional Chinese medicine for the treatment of bone disorders; however, its bioactive components and underlying mechanisms remain inadequately characterized. This study investigated the potential anti-osteoporotic constituents and mechanisms of CSR by integrating UPLC-Q-TOF-MS/MS, zebrafish and MC3T3-E1 cellular models, network pharmacology, molecular dynamics (MD) simulations, and RT-qPCR validation. Phenotypic evaluations showed that CSR aqueous extract significantly mitigated vertebral bone mineralization loss in glucocorticoid-induced zebrafish, while promoting cell proliferation and ALP activity in dexamethasone-treated MC3T3-E1 osteoblasts. Chemical profiling identified 21 components in the extract. Five candidate active ingredients and key targets were screened via network pharmacology, with predicted enrichment in the HIF-1 and VEGF signaling pathways. Molecular docking and 100 ns MD simulations predicted favorable binding poses and conformational stability between candidate compounds and core targets. Furthermore, maslinic acid, a candidate bioactive triterpenoid, improved cellular readouts under glucocorticoid challenge and was associated with reduced Casp3 mRNA and increased Runx2, Vegfa, and Mapk3 mRNA. These findings provide valuable insights into the multi-component osteoprotective potential of CSR, providing a solid scientific foundation for its future mechanistic exploration and therapeutic development.
Förderung
- Jilin Provincial Key Research and Development Plan Project
- Pilot Selection Projects of Universities and Research Institutes in Changchun
Zitieren
APA
Li, Y., Shen, J., Liu, J., Wu, P., Gao, F., Yang, B., Zhang, T., Zhang, H., Fan, J., Li, C., & Sun, J. (2026). Integrated Chemical Profiling, Network Pharmacology, and Zebrafish/Cellular Models Identify Potential Anti-Osteoporotic Constituents of Cynomorium songaricum Rupr. Current Issues in Molecular Biology, 48(11), 1137. https://doi.org/10.3390/cimb48111137
Vancouver
Li Y, Shen J, Liu J, Wu P, Gao F, Yang B, et al. Integrated Chemical Profiling, Network Pharmacology, and Zebrafish/Cellular Models Identify Potential Anti-Osteoporotic Constituents of Cynomorium songaricum Rupr. Current Issues in Molecular Biology. 2026;48(11):1137. doi:10.3390/cimb48111137
BibTeX
@article{Li2026,
author = {Li, Yajing and Shen, Jiaming and Liu, Junyu and Wu, Peitong and Gao, Fangxun and Yang, Bing and Zhang, Tong and Zhang, Huijia and Fan, Jizhou and Li, Chunnan and Sun, Jiaming},
title = {Integrated Chemical Profiling, Network Pharmacology, and Zebrafish/Cellular Models Identify Potential Anti-Osteoporotic Constituents of Cynomorium songaricum Rupr},
journal = {Current Issues in Molecular Biology},
year = {2026},
volume = {48},
number = {11},
pages = {1137},
doi = {10.3390/cimb48111137}
}
EUVIMED